Apellis Pharmaceuticals IncCompany Details

Get alertedif Apellis Pharmaceuticals Inc gets funded!
Apellis Pharmaceuticals IncFunding history
Key people
United States
Detailed industries:biotechnology
Company description

Apellis is a clinical stage immunotherapy company and targets the complement pathways to correct auto-immune conditions.


Funding history

DateDeal sizeInvestors 
December 2nd, 2014$33,000,000Aju Ib Investment Co Ltd, Epidarex Ventures, Morningside VenturesView Deal
August 21st, 2014$17,842,487-View Deal
July 25th, 2012$692,995-View Deal
June 1st, 2011$1,688,500-View Deal
May 21st, 2010$1,700,000-View Deal
Create alert
Want to know when Apellis Pharmaceuticals Inc gets funded?
Key people
Marie-claude BernalDirector
Gerald ChanDirector
David DarstDirector
David Darst, Jr.Director
Pascal DeschateletsCo-founder & Chief Operating Officer, Director, Executive Officer, Executive_Officer, Founder & Chief Operating Officer
Cedric FrancoisCo-founder & Chief Executive Officer/President, Director, Executive Officer, Executive_Officer
Stephen GilliesDirector
Angus MclachlanBiomedical Engineer
Douglas OnsiDirector
Mike YeadonConsultant Acting Chief Scientific Officer
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!